JPWO2021112185A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021112185A5
JPWO2021112185A5 JP2021562720A JP2021562720A JPWO2021112185A5 JP WO2021112185 A5 JPWO2021112185 A5 JP WO2021112185A5 JP 2021562720 A JP2021562720 A JP 2021562720A JP 2021562720 A JP2021562720 A JP 2021562720A JP WO2021112185 A5 JPWO2021112185 A5 JP WO2021112185A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562720A
Other languages
English (en)
Japanese (ja)
Other versions
JP7810556B2 (ja
JPWO2021112185A1 (https=
Filing date
Publication date
Priority claimed from PCT/JP2019/047956 external-priority patent/WO2021111636A1/ja
Application filed filed Critical
Publication of JPWO2021112185A1 publication Critical patent/JPWO2021112185A1/ja
Publication of JPWO2021112185A5 publication Critical patent/JPWO2021112185A5/ja
Priority to JP2025163286A priority Critical patent/JP2026004412A/ja
Application granted granted Critical
Publication of JP7810556B2 publication Critical patent/JP7810556B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2021562720A 2019-12-06 2020-12-03 抗ｇｄｆ１５抗体 Active JP7810556B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025163286A JP2026004412A (ja) 2019-12-06 2025-09-30 抗ｇｄｆ１５抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2019/047956 WO2021111636A1 (ja) 2019-12-06 2019-12-06 抗ｇｄｆ１５抗体
JPPCT/JP2019/047956 2019-12-06
PCT/JP2020/045062 WO2021112185A1 (ja) 2019-12-06 2020-12-03 抗ｇｄｆ１５抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025163286A Division JP2026004412A (ja) 2019-12-06 2025-09-30 抗ｇｄｆ１５抗体

Publications (3)

Publication Number Publication Date
JPWO2021112185A1 JPWO2021112185A1 (https=) 2021-06-10
JPWO2021112185A5 true JPWO2021112185A5 (https=) 2023-09-05
JP7810556B2 JP7810556B2 (ja) 2026-02-03

Family

ID=76221180

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021562720A Active JP7810556B2 (ja) 2019-12-06 2020-12-03 抗ｇｄｆ１５抗体
JP2025163286A Pending JP2026004412A (ja) 2019-12-06 2025-09-30 抗ｇｄｆ１５抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025163286A Pending JP2026004412A (ja) 2019-12-06 2025-09-30 抗ｇｄｆ１５抗体

Country Status (9)

Country Link
US (1) US20230036655A1 (https=)
EP (1) EP4070816A4 (https=)
JP (2) JP7810556B2 (https=)
KR (1) KR20220110522A (https=)
CN (1) CN114746443A (https=)
AU (1) AU2020396341A1 (https=)
CA (1) CA3164041A1 (https=)
TW (1) TW202128751A (https=)
WO (2) WO2021111636A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116444667B (zh) * 2023-06-13 2023-09-01 上海驯鹿生物技术有限公司 一种靶向gdf15的全人源抗体及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
JP3117662B2 (ja) 1997-08-07 2000-12-18 セキ工業株式会社 パーツ整列装置
US9212221B2 (en) * 2010-03-03 2015-12-15 Detroit R & D, Inc. Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
RS59045B1 (sr) * 2012-09-26 2019-08-30 Univ Wuerzburg J Maximilians Monoklonalna antitela za faktor 15 rasta i diferencijacije (gdf-15)
ES2791183T3 (es) 2012-12-21 2020-11-03 Aveo Pharmaceuticals Inc Anticuerpos anti-GDF15
TW201619200A (zh) * 2014-10-10 2016-06-01 麥迪紐有限責任公司 人類化抗－ｏｘ４０抗體及其用途
CN108463246B (zh) * 2015-10-02 2025-02-28 尤利乌斯·马克西米利安维尔茨堡大学 使用人生长分化因子15(gdf-15)抑制剂和免疫检查点阻断剂的联合治疗
WO2017189724A1 (en) * 2016-04-27 2017-11-02 Novartis Ag Antibodies against growth differentiation factor 15 and uses thereof
KR20230107309A (ko) * 2020-11-10 2023-07-14 카탈임 게엠베하 항-gdf15 항체 및 암 치료용 투여 용법

Similar Documents

Publication Publication Date Title
JP2019122405A5 (https=)
JP2022537931A5 (https=)
JP2019522961A5 (https=)
JP2020055849A5 (https=)
RU2012147286A (ru) Гуманизированные антитела к фактору d и их применения
RU2022101604A (ru) Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином
JP2022507487A5 (https=)
JP2021522162A5 (https=)
JP2018537966A5 (https=)
JP2022520672A5 (https=)
JP2011504501A5 (https=)
JP2012500020A5 (https=)
JP2024501539A5 (https=)
JP2021521781A5 (https=)
HRP20120759T1 (hr) Bispecifična veziva specifična između vrsta
JP2022513043A5 (https=)
RU2022108410A (ru) Терапевтические антитела против лиганда cd40
JP2022545647A5 (https=)
JP2019534277A5 (https=)
JP2022547733A5 (https=)
RU2019124709A (ru) КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА
JP2021509012A5 (https=)
DE60114829T2 (de) Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen
JP2021520393A5 (https=)
CR20240482A (es) Anticuerpos anti-tl1a y métodos de uso de los mismos